Holly Sheffield to Join as EVP, Chief Strategy Officer
Robert Auerbach Appointed President, CooperSurgical
PLEASANTON, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced the following key management changes:
Holly Sheffield has been appointed Executive Vice President and Chief Strategy Officer of The Cooper Companies, effective June 4, 2018. In this position, Holly will be responsible for corporate strategy, business development and global human resources with a strong focus on driving long-term shareholder value. Holly will report directly to Albert White, President and CEO.
Sheffield joins Cooper from UBS Securities LLC where she was Global Head of Medical Technology within the firms’ Healthcare Banking group. Holly was also co-head of the America’s Investment Bank Diversity and Inclusion Council at UBS along with involvement in several other cultural initiatives within the bank. Prior to UBS, she spent 13 years at Credit Suisse where she was a Managing Director in Healthcare Banking in San Francisco and New York. Sheffield holds an MBA from Columbia Business School and a BA from Cornell University.
Dr. Robert Auerbach, Executive Vice President, Chief Strategy Officer and Chief Medical Officer of CooperSurgical, has been promoted to President of CooperSurgical, effective April 17, 2018. In his new role, he is responsible for CooperSurgical’s worldwide business, reporting directly to Albert White. Auerbach has held a number of leadership roles since joining CooperSurgical in 2005. Prior to joining CooperSurgical, Auerbach was a member of Yale’s clinical faculty in the School of Medicine. He completed his specialty training in obstetrics and gynecology at Yale in 1988. Auerbach succeeds Paul Remmell who has transitioned out of the company after a successful career spanning 27 years.
Commenting on the announcement, White said, “I am very pleased with Holly and Bob’s appointments to our executive management team. Holly brings extensive knowledge and experience in the medical device space, and she will serve as an integral advisor and partner to our leadership team. Bob’s extensive experience as a leader within CooperSurgical for many years, combined with his technical expertise, makes him the ideal candidate to drive CooperSurgical’s global success.”
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 11,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT:
Kim Duncan
Vice President, Investor Relations
The Cooper Companies, Inc.
ir@cooperco.com